Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesOxford BioMedica PLC

Oxford BioMedica PLC

Healthcare Biotechnology
PortfolioPortfolio WatchlistWatchlist
Company price
532.0 GBX 5.00 ( 0.95%)
Last update at 2026-10-27T16:39:00Z
VOLUME
130824
Market Cap
683.08M

Momentum Score

…

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems; InAAVate, a proprietary "plug and play' dual-plasmid system for transient transfection, as well as a standard triple transfection system for AAV-based gene therapies. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, adenoviral vectors, and other viral vector types. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
510.00
Low
542.00
High
52 Week Price Range
270.00
Low
962.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
527.00
Dividend Yield
-
Revenue TTM
168.74M
Revenue Per Share
1.51
Gross Profit TTM
65.98M
Debt / Equity
1.17
ROE
-40.37%
Net Debt
9.76M
ROCE
-13.89%
Diluted EPS TTM
-0.27

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -31.94M -47.27M -188.53M -45.98M 19.88M
Minority interest 0.52M 5.42M 26.67M 6.00M -
Net income -30.13M -43.19M -157.49M -45.16M 19.01M
Selling general administrative 36.76M 29.42M 25.41M 28.22M 15.15M
Selling and marketing expenses - - 0.07M - -
Gross profit 65.98M 53.02M 39.73M 69.18M 82.64M
Reconciled depreciation 19.84M 22.43M 28.71M 26.36M 12.46M
Ebit - -37.43M -177.33M -51.56M 20.77M
Ebitda -33.54M -14.33M -148.62M -24.23M 33.39M
Depreciation and amortization - 23.09M 28.71M 27.33M 12.62M
Operating income -33.54M -39.38M -184.17M -51.56M 20.77M
Other operating expenses 202.28M 168.17M 273.71M 191.55M 121.86M
Interest expense 17.43M 9.84M 11.20M 16.73M 0.89M
Tax provision -1.29M 1.34M -4.37M -0.82M 0.87M
Interest income 5.18M 3.24M 4.91M 0.97M 0.00M
Net interest income -9.32M -7.27M -6.29M -15.76M -0.89M
Income tax expense -1.29M 1.34M -4.37M -0.82M 0.87M
Total revenue 168.74M 128.80M 89.54M 139.99M 142.80M
Total operating expenses 99.52M 92.40M 223.90M 120.74M 61.71M
Cost of revenue 102.76M 75.78M 49.81M 70.81M 60.16M
Total other income expense net 1.61M -7.89M -4.35M 5.58M -0.89M
Net income from continuing ops -30.64M -48.61M -184.16M -45.16M 19.01M
Net income applicable to common shares - - - - 19.01M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 325.72M 231.64M 252.34M 460.18M 237.23M
Intangible assets 25.17M 29.22M 30.98M 105.22M 0.05M
Other current assets 6.26M 16.86M 11.40M - 45.30M
Total liab 234.37M 171.16M 174.51M 223.99M 49.89M
Total stockholder equity 91.35M 57.05M 74.01M 204.65M 187.34M
Other current liab 63.95M 44.29M 29.48M 42.76M 27.19M
Common stock - 52.98M 48.40M 48.13M 43.09M
Capital stock 60.38M 52.98M 48.40M 48.13M 43.09M
Retained earnings -422.35M -399.50M -352.92M -198.54M -165.81M
Other liab - - - - 8.10M
Good will 0.00M 0.00M 0.00M 0.66M -
Other assets - - - - 3.60M
Cash 96.88M 60.65M 103.72M 141.28M 108.94M
Total current liabilities 84.22M 58.32M 44.31M 59.66M 33.31M
Current deferred revenue - 24.19M 22.11M - -
Net debt 9.76M 48.11M 7.74M -27.00M -99.60M
Short term debt 6.06M 4.42M 7.31M 3.29M 0.85M
Short long term debt 0.00M 0.28M 0.00M - -
Short long term debt total 106.64M 108.76M 111.46M 114.28M 9.34M
Other stockholder equity 513.70M 394.86M 380.33M 355.07M 310.06M
Property plant equipment - - - - 69.73M
Total current assets 185.65M 133.19M 141.33M 215.50M 163.84M
Net tangible assets - - - - 187.29M
Short term investments - - - 0.02M 0.07M
Net receivables 65.18M 42.11M 13.34M 34.11M 22.40M
Long term debt 41.49M 39.79M 38.53M 39.78M -
Inventory 17.33M 13.57M 12.87M 12.62M 9.52M
Accounts payable 14.21M 9.61M 6.05M 13.60M 5.26M
Accumulated other comprehensive income - 8.71M -1.81M - -
Non currrent assets other - 4.93M 4.34M 5.01M 3.60M
Non current assets total 140.07M 98.45M 111.01M 244.68M 73.39M
Capital lease obligations 106.64M 68.69M 72.92M 74.50M 9.34M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - 5.63M 2.81M -56.46M -9.46M
Change to liabilities - - - - -17.19M
Total cashflows from investing activities -8.10M 5.63M 2.81M - -9.46M
Net borrowings 3.18M -0.47M 0.00M - -4.52M
Total cash from financing activities 50.59M 2.91M -12.70M 98.62M 46.21M
Net income -30.13M -47.27M -157.49M -45.98M 19.88M
Change in cash 36.23M -43.07M -37.57M 32.34M 62.20M
Begin period cash flow 60.65M 103.72M 141.28M 108.94M 46.74M
End period cash flow 96.88M 60.65M 103.72M 141.28M 108.94M
Total cash from operating activities -5.45M -50.63M -28.52M -12.62M 25.45M
Issuance of capital stock 58.06M 17.53M 0.65M 80.15M 51.60M
Depreciation 19.84M 22.43M 28.71M 26.36M 12.46M
Other cashflows from investing activities - 4.12M 12.64M - -
Change to inventory -1.85M 2.19M -0.25M 0.67M -2.61M
Change to account receivables -21.66M -33.34M 28.79M - 6.89M
Other cashflows from financing activities -10.64M -14.15M -10.24M 49.89M -5.39M
Change to netincome - - - - 6.90M
Capital expenditures 4.76M 7.50M 9.83M 16.30M 9.46M
Change in working capital 3.23M -34.38M 17.46M 4.91M -12.91M
Stock based compensation 4.68M 1.69M 3.52M 6.47M 3.98M
Other non cash items 21.45M 8.59M 79.29M -4.38M 1.05M
Free cash flow -10.21M -58.12M -38.35M -28.91M 15.99M

Peer Comparison*

Sector: Healthcare Industry: Biotechnology

Stock Name
Change
(GBX)
Price
(GBX)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
OXB
Oxford BioMedica PLC		 5.00
0.95%		 532.00 - 208.33 4.05 7.60 4.42 308.96
GNS
Genus PLC		 18.00
0.78%		 2340.00 36.08 26.18 2.53 3.46 2.92 15.38
ONT
Oxford Nanopore Technologies Ltd		 10.60
4.93%		 225.60 - - 4.71 2.50 4.23 -8.89
AVCT
Avacta Group PLC		 -1.00
1.60%		 61.50 - - 2849.46 1929.84 2525.51 -12.04
IBT
International Biotechnology Trust plc		 5.00
0.49%		 1020.00 - 714.29 16.40 1.20 15.60 -

Profile*

Oxford BioMedica PLC

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems; InAAVate, a proprietary "plug and play' dual-plasmid system for transient transfection, as well as a standard triple transfection system for AAV-based gene therapies. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, adenoviral vectors, and other viral vector types. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom.

Windrush Court, Oxford, United Kingdom, OX4 6LT

44 1865 783 000

https://www.oxb.com

977

Name Title Year Born
Dr. Roch Doliveux Interim CEO & Chairman NA
Mr. Stuart Paynter CFO, Company Sec. & Director 1974
Mr. Nick Page Chief Operations Officer NA
Dr. James Miskin Ph.D. Chief Technical Officer NA
Dr. Kyriacos Mitrophanous Ph.D. Chief Scientific Officer NA
Mr. Matthew Treagus Chief Information Officer NA
Sophia Bolhassan Head of Investor Relations NA
Ms. Natalie Louise Walter Gen. Counsel NA
Dr. Jason Slingsby MBA Chief Bus. & Corp. Devel. Officer NA
Ms. Sarah Macleod Head of Communications NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

PRL
CAD 29.99
+13.13%
AP-UN
CAD 4.19
+12.94%
ARTG
CAD 39.66
+12.93%
BZ
CAD 4.14
+10.99%
FFH
CAD 2759.48
+10.87%
DRUG
CAD 27.12
-26.86%
HUT
CAD 69.10
-22.27%
UCU
CAD 2.04
-16.39%
PHX
CAD 10.85
-14.43%
MOON
CAD 4.09
-12.79%

Equity Sectors*

  • Basic Materials

    +3.69%

  • Communication Services

    +2.61%

  • Consumer Cyclical

    +2.96%

  • Consumer Defensive

    +1.11%

  • Energy

    -5.01%

  • Financial Services

    +2.20%

  • Healthcare

    -0.56%

  • Industrials

    -0.73%

  • Real Estate

    +1.90%

  • Technology

    +0.05%

  • Utilities

    +1.39%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…